CMXHF
Price
$152.18
Change
-$0.21 (-0.14%)
Updated
Jul 10 closing price
Capitalization
76.77B
IDRSF
Price
$3.02
Change
+$0.22 (+7.86%)
Updated
Jul 10 closing price
Capitalization
575.11M
Interact to see
Advertisement

CMXHF vs IDRSF

Header iconCMXHF vs IDRSF Comparison
Open Charts CMXHF vs IDRSFBanner chart's image
CSL
Price$152.18
Change-$0.21 (-0.14%)
Volume$5.12K
Capitalization76.77B
Idorsia AG
Price$3.02
Change+$0.22 (+7.86%)
Volume$1.01K
Capitalization575.11M
CMXHF vs IDRSF Comparison Chart in %
Loading...
CMXHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMXHF vs. IDRSF commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMXHF is a Hold and IDRSF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (CMXHF: $152.18 vs. IDRSF: $3.02)
Brand notoriety: CMXHF and IDRSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMXHF: 28% vs. IDRSF: 124%
Market capitalization -- CMXHF: $76.77B vs. IDRSF: $575.11M
CMXHF [@Biotechnology] is valued at $76.77B. IDRSF’s [@Biotechnology] market capitalization is $575.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMXHF’s FA Score shows that 1 FA rating(s) are green whileIDRSF’s FA Score has 0 green FA rating(s).

  • CMXHF’s FA Score: 1 green, 4 red.
  • IDRSF’s FA Score: 0 green, 5 red.
According to our system of comparison, CMXHF is a better buy in the long-term than IDRSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMXHF’s TA Score shows that 4 TA indicator(s) are bullish while IDRSF’s TA Score has 4 bullish TA indicator(s).

  • CMXHF’s TA Score: 4 bullish, 4 bearish.
  • IDRSF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, IDRSF is a better buy in the short-term than CMXHF.

Price Growth

CMXHF (@Biotechnology) experienced а -0.36% price change this week, while IDRSF (@Biotechnology) price change was +25.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMXHF($76.8B) has a higher market cap than IDRSF($575M). CMXHF has higher P/E ratio than IDRSF: CMXHF (27.92) vs IDRSF (4.54). IDRSF YTD gains are higher at: 254.706 vs. CMXHF (-8.254). CMXHF has higher annual earnings (EBITDA): 4.73B vs. IDRSF (-189.01M). CMXHF has more cash in the bank: 1.52B vs. IDRSF (64.8M). IDRSF has less debt than CMXHF: IDRSF (1.25B) vs CMXHF (12B). CMXHF has higher revenues than IDRSF: CMXHF (14.7B) vs IDRSF (161M).
CMXHFIDRSFCMXHF / IDRSF
Capitalization76.8B575M13,357%
EBITDA4.73B-189.01M-2,504%
Gain YTD-8.254254.706-3%
P/E Ratio27.924.54616%
Revenue14.7B161M9,130%
Total Cash1.52B64.8M2,352%
Total Debt12B1.25B957%
FUNDAMENTALS RATINGS
CMXHF vs IDRSF: Fundamental Ratings
CMXHF
IDRSF
OUTLOOK RATING
1..100
2844
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
53100
PRICE GROWTH RATING
1..100
6234
P/E GROWTH RATING
1..100
8398
SEASONALITY SCORE
1..100
5042

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMXHF's Valuation (2) in the null industry is significantly better than the same rating for IDRSF (81). This means that CMXHF’s stock grew significantly faster than IDRSF’s over the last 12 months.

CMXHF's Profit vs Risk Rating (100) in the null industry is in the same range as IDRSF (100). This means that CMXHF’s stock grew similarly to IDRSF’s over the last 12 months.

CMXHF's SMR Rating (53) in the null industry is somewhat better than the same rating for IDRSF (100). This means that CMXHF’s stock grew somewhat faster than IDRSF’s over the last 12 months.

IDRSF's Price Growth Rating (34) in the null industry is in the same range as CMXHF (62). This means that IDRSF’s stock grew similarly to CMXHF’s over the last 12 months.

CMXHF's P/E Growth Rating (83) in the null industry is in the same range as IDRSF (98). This means that CMXHF’s stock grew similarly to IDRSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMXHFIDRSF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
50%
Advances
ODDS (%)
Bullish Trend 4 days ago
48%
Bullish Trend 2 days ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
45%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
CMXHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTRK0.440.02
+3.79%
Ontrak Inc
ARKO4.630.09
+1.98%
ARKO Corp
WLK86.480.99
+1.16%
Westlake Corp
UBFO8.940.04
+0.45%
United Security Bancshares
CRNX31.99-0.34
-1.05%
Crinetics Pharmaceuticals

CMXHF and

Correlation & Price change

A.I.dvisor tells us that CMXHF and ACRV have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMXHF and ACRV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMXHF
1D Price
Change %
CMXHF100%
-0.14%
ACRV - CMXHF
26%
Poorly correlated
+0.75%
ADCT - CMXHF
21%
Poorly correlated
+4.76%
IDRSF - CMXHF
21%
Poorly correlated
+7.68%
ARVN - CMXHF
20%
Poorly correlated
-4.13%
DSGN - CMXHF
20%
Poorly correlated
-3.12%
More

IDRSF and

Correlation & Price change

A.I.dvisor tells us that IDRSF and KRRO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDRSF and KRRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDRSF
1D Price
Change %
IDRSF100%
+7.68%
KRRO - IDRSF
29%
Poorly correlated
-7.68%
VYGR - IDRSF
24%
Poorly correlated
+11.64%
ENLV - IDRSF
23%
Poorly correlated
+3.08%
GLABF - IDRSF
23%
Poorly correlated
N/A
IVEVF - IDRSF
21%
Poorly correlated
N/A
More